| 2026-05-07 |
详情>>
业绩披露：
2026年一季报每股收益-0.59美元,归母净利润-4416.2万美元,同比去年增长-95.1%
|
| 2026-05-07 |
财报披露：
美东时间 2026-05-07 盘后发布财报
|
| 2026-03-02 |
详情>>
股本变动：
变动后总股本7374.96万股
|
| 2026-03-02 |
详情>>
业绩披露：
2023年年报每股收益-1.72美元,归母净利润-1.19亿美元,同比去年增长-195.44%
|
| 2026-03-02 |
详情>>
业绩披露：
2025年年报每股收益-1.08美元,归母净利润-8113万美元,同比去年增长33.88%
|
| 2026-01-12 |
详情>>
内部人交易：
Galbraith Kenneth等共交易8笔
|
| 2025-11-10 |
股东大会：
将于2025-12-30召开股东大会
会议内容 ▼▲
- 1.To elect as Class I directors the three nominees named in the proxy statement to hold office until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified, subject to earlier resignation or removal;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of KPMG LLP, chartered professional accountants (“KPMG”), as auditors for the Company for the year ending December 31, 2025;
4.To transact such other business that may properly come before the Meeting.
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.53美元,归母净利润-3992.1万美元,同比去年增长59.75%
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-0.27美元,归母净利润-2031.9万美元,同比去年增长70.70%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.3美元,归母净利润-2263.6万美元,同比去年增长28.49%
|
| 2025-03-05 |
详情>>
业绩披露：
2024年年报每股收益-1.62美元,归母净利润-1.23亿美元,同比去年增长-3.39%
|
| 2025-03-05 |
详情>>
业绩披露：
2022年年报每股收益1.91美元,归母净利润1.24亿美元,同比去年增长158.69%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.3美元,归母净利润-9918.9万美元,同比去年增长4.80%
|
| 2024-10-29 |
股东大会：
将于2024-12-10召开股东大会
会议内容 ▼▲
- 1.To elect as Class III directors the four nominees named in the proxy statement to hold office until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified, subject to earlier resignation or removal;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of KPMG LLP, chartered professional accountants (“KPMG”), as auditors for the Company for the year ending December 31, 2024;
4.To transact such other business that may properly come before the Meeting.
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.91美元,归母净利润-6933.9万美元,同比去年增长8.17%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.42美元,归母净利润-3165.3万美元,同比去年增长-29.98%
|
| 2023-10-26 |
股东大会：
将于2023-12-07召开股东大会
会议内容 ▼▲
- 1.To elect as Class II directors the three nominees named in the proxy statement to hold office until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified, subject to earlier resignation or removal;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of KPMG LLP, chartered professional accountants (“KPMG”), as auditors for the Company for the year ending December 31, 2023;
4.To transact such other business that may properly come before the Meeting.
|
| 2022-09-02 |
股东大会：
将于2022-10-07召开股东大会
会议内容 ▼▲
- 1.To consider and, if deemed advisable, to approve, with or without variation, a special resolution of the Zymeworks Securityholders (the “Redomicile Resolution”) to approve a series of transactions, including a corporate redomicile (collectively, the “Redomicile Transactions”), which will include a proposed plan of arrangement under the BCBCA that provides for, among other things, (a) the issuance to Zymeworks Shareholders, at their election and subject to applicable eligibility criteria, for their Zymeworks Common Shares, of either (i) shares of Zymeworks Delaware Inc., a Delaware corporation, (“Parent”) common stock, par value $0.00001 per share (the “Delaware Common Stock”) on a one-for-one basis, or (ii) exchangeable shares (the “Exchangeable Shares” and recipients thereof, the “Exchangeable Shareholders”) in the capital of Zymeworks ExchangeCo Ltd., a company existing under the laws of the Province of British Columbia and a direct wholly-owned subsidiary of Callco (“ExchangeCo”), on a one-for-one basis, or a mix of Exchangeable Shares and Delaware Common Stock (in such aggregate number that is equal to the number of Zymeworks Common Shares exchanged for them) (the “Mixed Election”), but subject to a cap on the aggregate number of Exchangeable Shares that is equal to 18% of (1) the number of Zymeworks Common Shares issued and outstanding, less (2) the number of Zymeworks Common Shares held by any Zymeworks Shareholders who exercise their Dissent Rights (the “Exchangeable Share Cap”); (b) the entry by Parent, Zymeworks CallCo ULC, an unlimited liability company existing under the laws of the Province of British Columbia and a direct, wholly-owned subsidiary of Parent (“Callco”) and ExchangeCo into the Exchangeable Share Support Agreement (the “Support Agreement”); and (c) the entry by Parent, ExchangeCo, Callco and Computershare Trust Company of Canada, a trust company existing under the laws of Canada (the “Share Trustee”) into the Voting and Exchange Trust Agreement (the “Trust Agreement”) for the benefit of the Exchangeable Shareholders, as more particularly described in the accompanying proxy statement/prospectus of Zymeworks dated September 2, 2022 (as may be amended, supplemented or otherwise modified from time to time) (the “Proxy Statement/Prospectus”);
2.To transact such other business as may properly come before the Special Meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-23 |
股东大会：
将于2021-05-05召开股东大会
会议内容 ▼▲
- 1.the election of three members of the board of directors of the Company to hold office until the 2024 annual meeting of shareholders or until their successors are elected and qualified, subject to earlier resignation or removal;
2.a non-binding resolution to approve the compensation of our named executive officers as disclosed in this proxy statement;
3.the appointment of KPMG LLP, chartered professional accountants, as auditors for the Company for the ensuing year and the authorization of the board of directors of the Company to fix the remuneration to be paid to the auditor;
4.the consideration of other matters that may properly come before the Meeting.
|
| 2020-03-23 |
股东大会：
将于2020-05-07召开股东大会
会议内容 ▼▲
- 1.the election of two members of the board of directors of the Company to hold office until the 2023 annual meeting of shareholders or until their successors are elected and qualified, subject to earlier resignation or removal;
2.a non-binding resolution to approve the compensation of our named executive officers as disclosed in this proxy statement;
3.a non-binding resolution to approve the preferred frequency of shareholder advisoryes on the compensation of the Company’s named executive officer
4.the appointment of KPMG LLP, chartered professional accountants, as auditors for the Company for the ensuing year and the authorization of the board of directors of the Company to fix the remuneration to be paid to the auditor;
5.the consideration of other matters that may properly come before the Meeting.
|
| 2019-03-18 |
股东大会：
将于2019-05-02召开股东大会
会议内容 ▼▲
- 1.the election of two members of the board of directors of the Company to hold office until the 2022 annual meeting of shareholders or until their successors are elected and qualified, subject to earlier resignation or removal;
2.the appointment of KPMG LLP, chartered professional accountants, as auditors for the Company for the ensuing year and the authorization of the board of directors of the Company to fix the remuneration to be paid to the auditor;
3.the consideration of other matters that may properly come before the Meeting.
|
| 2018-06-02 |
复牌提示：
2018-06-01 15:40:03 停牌，复牌日期 2018-06-01 15:56:48
|